Literature DB >> 27349954

Successful liver transplantation for hepatocellular carcinoma following down-staging using sorafenib single therapy.

Patrick Borentain1, Emilie Gregoire2, Guillaume Louis3, René Gerolami1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27349954     DOI： 10.1111/liv.13190

Source DB:  PubMed          Journal:  Liver Int        ISSN： 1478-3223            Impact factor:   5.828


× No keyword cloud information.
  5 in total

1.  Twenty years after: from Milan criteria to a "blended" approach.

Authors:  Giovanni Battista Levi Sandri; Quirino Lai
Journal:  Transl Gastroenterol Hepatol       Date:  2017-07-21

Review 2.  Hepatocellular carcinoma: when is liver transplantation oncologically futile?

Authors:  André Viveiros; Heinz Zoller; Armin Finkenstedt
Journal:  Transl Gastroenterol Hepatol       Date:  2017-07-24

3.  Chemotherapy regimen based on sorafenib combined with 5-FU on HIF-1α and VEGF expression and survival in advanced gastric cancer patients.

Authors:  Ronghui Cheng; Hongmei Yong; Yunhong Xia; Qingsong Xie; Guangyi Gao; Xueyi Zhou
Journal:  Oncol Lett       Date:  2017-02-23       Impact factor: 2.967

Review 4.  Neoadjuvant treatment strategies for hepatocellular carcinoma.

Authors:  Lei Xu; Lin Chen; Wei Zhang
Journal:  World J Gastrointest Surg       Date:  2021-12-27

5.  Improved treatment of early small hepatocellular carcinoma using sorafenib in combination with radiofrequency ablation.

Authors:  Quanyou Gong; Zhaoxia Qin; Fangli Hou
Journal:  Oncol Lett       Date:  2017-10-12       Impact factor: 2.967
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.